Skip to main content
SpringerLink
Log in

Prevalence and Spectrum Diseases Predisposing to Sudden Cardiac Death: Are They the Same for Both the Athlete and the Nonathlete?

  • Review Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Sudden cardiac death (SCD) is a rare but devastating event among young people. The precise scale of the event remains undefined. This uncommon but catastrophic event usually is proved to be the consequence of varied unsuspected congenital or acquired cardiovascular diseases. Hypertrophic cardiomyopathy and coronary artery anomalies are the two most frequent causes of SCD. Most commonly, SCD resulting from these diseases occurs during or immediately after exercise. This report highlights the prevalence and spectrum of SCD-predisposing diseases and how they are affected by athletic participation. In addition, disease-specific guidelines for sports participation are addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ackerman MJ (2009) State of postmortem genetic testing known as the cardiac channel molecular autopsy in the forensic evaluation of unexplained sudden cardiac death in the young. Pacing Clin Electrophysiol 32:S86–S89

    Article  PubMed  Google Scholar 

  2. Basso C, Maron BJ, Corrado D et al (2000) Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol 35:1493–1501

    Article  PubMed  CAS  Google Scholar 

  3. Brucato A (2008) Prevention of congenital heart block in children of SSA-positive mothers. Rheumatology 47:S35–S37

    Article  Google Scholar 

  4. Cheitlin MD, MacGregor J (2009) Congenital anomalies of coronary arteries: role in the pathogenesis of sudden cardiac death. Herz 34:268–279

    Article  PubMed  Google Scholar 

  5. Chugh SS, Reinier K, Balaji S, Uy-Evanado A, Vickers C, Mariani R, Gunson K, Jui J (2009) Population-based analysis of sudden death in children: the Oregon sudden unexpected death study. Heart Rhythm 6:1618–1622

    Article  PubMed  Google Scholar 

  6. Corrado D, Thiene G, Nava A et al (1990) Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med 39:588–596

    Article  Google Scholar 

  7. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G (2003) Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 42:1959–1963

    Article  PubMed  Google Scholar 

  8. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G (2006) Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 296:1593–1601

    Article  PubMed  CAS  Google Scholar 

  9. Day SM (2009) Exercise in hypertrophic cardiomyopathy. J Cardiovasc Transl Res 2:407–414

    Article  PubMed  Google Scholar 

  10. Douglas PS, O’Toole ML, Hiller WDB et al (1990) Different effects of prolonged exercise on the right and left ventricles. J Am Coll Cardiol 15:64–69

    Article  PubMed  CAS  Google Scholar 

  11. Driscoll DJ, Edwards WD (1985) Sudden unexpected death in children and adolescents. J Am Coll Cardiol 5:118B–121B

    Article  PubMed  CAS  Google Scholar 

  12. Eckart RE, Scoville SL, Campbell CL et al (2004) Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med 141:829–834

    PubMed  Google Scholar 

  13. Edwards CP, Yavari A, Sheppard MN, Sharma S (2010) Anomalous coronary origin: the challenge in preventing exercise-related sudden cardiac death. Br J Sports Med 44:895–897

    Article  PubMed  CAS  Google Scholar 

  14. Furlanello F, Bertoldi A, Inama G, Fernando F (1995) Catheter ablation in competitive athletes: indication. J Interv Cardiol 8:837–840

    Article  PubMed  CAS  Google Scholar 

  15. Gollob MH, Redpath CJ, Roberts JD (2011) The short QT syndrome: proposed diagnostic criteria. J Am Coll Cardiol 57:802–812

    Article  PubMed  Google Scholar 

  16. Harmon KG, Asif IM, Klossner D, Drezner JA (2011) Incidence of sudden cardiac death in national collegiate athletic association athletes. Circulation 123:1594–1600

    Article  PubMed  Google Scholar 

  17. Heidbüchel H, Corrado D, Biffi A et al (2006) Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II. Ventricular arrhythmias, channelopathies, and implantable defibrillators. Eur J Cardiovasc Prev Rehabil 13:676–686

    Article  PubMed  Google Scholar 

  18. Heidbüchel H, Panhuyzen-Goedkoop N et al (2006) Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions: Part I. Supraventricular arrhythmias and pacemakers. Eur J Cardiovasc Prev Rehabil 13:475–484

    Article  PubMed  Google Scholar 

  19. Hirth A, Reybrouck T, Bjarnason-Wehrens B, Lawrenz W, Hoffmann A (2006) Recommendations for participation in competitive and leisure sports in patients with congenital heart disease: a consensus document. Eur J Cardiovasc Prev Rehabil 13:293–299

    Article  PubMed  Google Scholar 

  20. Klein GJ, Gula LJ, Krahn AD, Skanes AC, Yee R (2009) WPW pattern in the asymptomatic individual: has anything changed? Circ Arrhythm Electrophysiol 2:97–99

    Article  PubMed  Google Scholar 

  21. Levine MC, Klugman D, Teach SJ (2010) Update on myocarditis in children. Curr Opin Pediatr 22:278–283

    Article  PubMed  Google Scholar 

  22. Liberthson RR (1996) Sudden death from cardiac causes in children and young adults. N Engl J Med 334:1039–1044

    Article  PubMed  CAS  Google Scholar 

  23. Maron BJ, Garson A (1994) Arrhythmias and sudden cardiac death in elite athletes. Cardiol Rev 2:26–32

    Article  Google Scholar 

  24. Maron BJ, Mitchell JH (1994) Revised eligibility recommendations for competitive athletes with cardiovascular abnormalities: introduction to Bethesda conference 26. J Am Coll Cardiol 24:848–850

    Article  PubMed  CAS  Google Scholar 

  25. Maron BJ, Zipes DP (2005) 36th Bethesda conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 45:2–64

    Article  Google Scholar 

  26. Maron BJ, Epstein SE, Roberts WC (1986) Causes of sudden death in the competitive athlete. J Am Coll Cardiol 7:204–214

    Article  PubMed  CAS  Google Scholar 

  27. Maron BJ, Gardin JM, Flack JM et al (1995) Assessment of the prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4,111 subjects in the CARDIA study. Circulation 92:785–789

    PubMed  CAS  Google Scholar 

  28. Maron BJ, Pelliccia A, Spirito R (1995) Cardiac disease in young trained athletes: insights into methods for distinguishing athlete’s heart from structural heart disease with particular emphasis on hypertrophic cardiomyopathy. Circulation 91:1596–1601

    PubMed  CAS  Google Scholar 

  29. Maron BJ, Gohman TE, Kyle SB, Estes NA III, Link MS (2002) Clinical profile and spectrum of commotio cordis. JAMA 287:1142–1146

    Article  PubMed  Google Scholar 

  30. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO (2009) Sudden deaths in young competitive athletes: analysis of 1,866 deaths in the United States, 1980–2006. Circulation 119:1085–1092

    Article  PubMed  Google Scholar 

  31. Maron BJ, Haas TS, Doerer JJ, Thompson PD, Hodges JS (2009) Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol 104:276–280

    Article  PubMed  Google Scholar 

  32. Pelliccia A, Maron BJ, Spataro A et al (1991) The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 324:295–301

    Article  PubMed  CAS  Google Scholar 

  33. Pelliccia A, Maron BJ, Culaasso F et al (1996) The athlete’s heart in women: echocardiographic characterization of 600 highly trained elite female athletes. JAMA 276:211–215

    Article  PubMed  CAS  Google Scholar 

  34. Pelliccia A, Fagard R, Bjørnstad HH et al (2005) Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and pericardial diseases of the European Society of Cardiology. Eur Heart J 26:1422–1445

    Article  PubMed  Google Scholar 

  35. Pelliccia A, Corrado D, Bjørnstad HH (2006) Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis, and pericarditis. Eur J Cardiovasc Prev Rehabil 13:876–885

    Article  PubMed  Google Scholar 

  36. Pelliccia A, Zipes DP, Maron BJ (2008) Bethesda conference #36 and the European Society of Cardiology consensus recommendations revisited: a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 52:1990–1996

    Article  PubMed  Google Scholar 

  37. Probst V, Denjoy I, Meregalli PG et al (2007) Clinical aspects and prognosis of Brugada syndrome in children. Circulation 115:2042–2048

    Article  PubMed  Google Scholar 

  38. Schwartz PJ (2006) The congenital long QT syndromes from genotype to phenotype: clinical implications. J Intern Med 259:39–47

    Article  PubMed  CAS  Google Scholar 

  39. Silka MJ, Hardy BG, Menashe VD, Morris CD (1998) A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 32:245–251

    Article  PubMed  CAS  Google Scholar 

  40. Spirito P, Seidman CE, McKenna SJ et al (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 36:775–785

    Article  Google Scholar 

  41. Stout M (2009) The Marfan syndrome: implications for athletes and their echocardiographic assessment. Echocardiography. 26:1075–1081

    Article  PubMed  Google Scholar 

  42. Sy RW, Gollob MH, Klein GJ et al (2011) Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 8(6):864–871

    Google Scholar 

  43. Tiso N, Stephan DA, Nava A et al (2001) Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10:189–194

    Article  PubMed  CAS  Google Scholar 

  44. Wichter T, Hindricks G, Lerch H et al (1994) Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. Circulation 89:667–683

    PubMed  CAS  Google Scholar 

  45. Winkler RB, Freed MD, Nadas AS (1980) Exercise-induced ventricular ectopy in children and young adults with complete heart block. Am Heart J 99:87–92

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Cardiology, Children’s Hospital of Orange County, University of California at Irvine, 455 S Main Street, Orange, CA, 92868, USA

    Anjan S. Batra

  2. Division of Cardiology, Oregon Health and Science University, Portland, OR, USA

    Seshadri Balaji

Authors
  1. Anjan S. Batra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seshadri Balaji
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anjan S. Batra.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Batra, A.S., Balaji, S. Prevalence and Spectrum Diseases Predisposing to Sudden Cardiac Death: Are They the Same for Both the Athlete and the Nonathlete?. Pediatr Cardiol 33, 379–386 (2012). https://doi.org/10.1007/s00246-012-0159-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-012-0159-1

Keywords

Search

Navigation